GAIN THERAPEUTICS, INC Increase (Decrease) in Accrued Taxes Payable
GAIN THERAPEUTICS, INC (GANX) reported Increase (Decrease) in Accrued Taxes Payable of $9.41 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2021-11-12
- GAIN THERAPEUTICS, INC increase (decrease) in accrued taxes payable for the quarter ending 2021-03-31 was $3.46K.
- GAIN THERAPEUTICS, INC increase (decrease) in accrued taxes payable for the quarter ending 2020-03-31 was -$2.35K.
| Period end | Increase (Decrease) in Accrued Taxes Payable 3 month | Increase (Decrease) in Accrued Taxes Payable 9 month |
|---|---|---|
| 2021-09-30 | $9.41K 10-Q · filed 2021-11-12 | |
| 2021-03-31 | $3.46K 10-Q · filed 2021-05-10 | |
| 2020-09-30 | $3.23K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | -$2.35K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |